Fredrik Conradi Schreuder
Presidente presso RespiNor AS
Profilo
Fredrik Conradi Schreuder is currently the Chairman at RespiNor AS and the Director at NeoRad AS.
He previously held positions as the Chairman at Algeta ASA and as the Senior Vice President at Hafslund Nycomed AS.
Posizioni attive di Fredrik Conradi Schreuder
| Società | Posizione | Inizio |
|---|---|---|
NeoRad AS
 NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Direttore/Membro del Consiglio | - |
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Presidente | - |
Precedenti posizioni note di Fredrik Conradi Schreuder
| Società | Posizione | Fine |
|---|---|---|
| ALGETA ASA | Presidente | - |
| Hafslund Nycomed AS | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
NeoRad AS
NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Health Technology |
| Hafslund Nycomed AS | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
- Borsa valori
- Insiders
- Fredrik Conradi Schreuder
